[Long-term prognosis of hepatocellular carcinoma patients treated with adoptive immunotherapy].

Abstract

Adoptive immunotherapy was performed for patients with multiple hepatocellular carcinoma (HCC) using LAK cells via the hepatic arterial catheter. One case study: A 45-year-old male patient was performed an absolute-non-cure operation. The operation was a success. However, some residual tumors remained in the liver. After the operation, adoptive… (More)

Topics

Cite this paper

@article{Takeda2004LongtermPO, title={[Long-term prognosis of hepatocellular carcinoma patients treated with adoptive immunotherapy].}, author={Tsutomu Takeda and Michiko Watanabe and Koji Umeshita and Mitsukazu Goto and Morito Monden}, journal={Gan to kagaku ryoho. Cancer & chemotherapy}, year={2004}, volume={31 11}, pages={1646-8} }